BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9140575)

  • 21. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans.
    Balali-Mood M; Hefazi M
    Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):273-82. PubMed ID: 17040211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of neutralized chemical agent identification sets (CAIS) for skin injury with an overview of the vesicant potential of agent degradation products.
    Olajos EJ; Olson CT; Salem H; Singer AW; Hayes TL; Menton RG; Miller TL; Rosso T; MacIver B
    J Appl Toxicol; 1998; 18(6):409-20. PubMed ID: 9840748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevention and treatment of cutaneous injury secondary to chemical warfare agents. Application of these finding to other dermatologic conditions and wound healing.
    Smith KJ
    Dermatol Clin; 1999 Jan; 17(1):41-60, viii. PubMed ID: 9986995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acute poisoning by chemical warfare agent: sulfur mustard].
    Mérat S; Perez JP; Rüttimann M; Bordier E; Lienhard A; Lenoir B; Pats B
    Ann Fr Anesth Reanim; 2003 Feb; 22(2):108-18. PubMed ID: 12706764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous and ocular late complications of sulfur mustard in Iranian veterans.
    Shohrati M; Peyman M; Peyman A; Davoudi M; Ghanei M
    Cutan Ocul Toxicol; 2007; 26(2):73-81. PubMed ID: 17612976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis and treatment of skin lesions caused by sulfur mustard.
    Poursaleh Z; Ghanei M; Babamahmoodi F; Izadi M; Harandi AA; Emadi SE; Taghavi NO; Sayad-Nouri SS; Emadi SN
    Cutan Ocul Toxicol; 2012 Sep; 31(3):241-9. PubMed ID: 22122127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time course of skin features and inflammatory biomarkers after liquid sulfur mustard exposure in SKH-1 hairless mice.
    Mouret S; Wartelle J; Batal M; Emorine S; Bertoni M; Poyot T; Cléry-Barraud C; Bakdouri NE; Peinnequin A; Douki T; Boudry I
    Toxicol Lett; 2015 Jan; 232(1):68-78. PubMed ID: 25275893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late cutaneous manifestations 14 to 20 years after wartime exposure to sulfur mustard gas: a long-term investigation.
    Emadi SN; Mortazavi M; Mortazavi H
    Arch Dermatol; 2008 Aug; 144(8):1059-61. PubMed ID: 18711087
    [No Abstract]   [Full Text] [Related]  

  • 29. Sulfur mustard: its continuing threat as a chemical warfare agent, the cutaneous lesions induced, progress in understanding its mechanism of action, its long-term health effects, and new developments for protection and therapy.
    Smith KJ; Hurst CG; Moeller RB; Skelton HG; Sidell FR
    J Am Acad Dermatol; 1995 May; 32(5 Pt 1):765-76. PubMed ID: 7722023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous histopathologic features in weanling pigs after exposure to three different doses of liquid sulfur mustard.
    Smith KJ; Skelton HG; Hobson DW; Reid FM; Blank JA; Hurst CG
    Am J Dermatopathol; 1996 Oct; 18(5):515-20. PubMed ID: 8902098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sulfur mustard skin lesions: A systematic review on pathomechanisms, treatment options and future research directions.
    Rose D; Schmidt A; Brandenburger M; Sturmheit T; Zille M; Boltze J
    Toxicol Lett; 2018 Sep; 293():82-90. PubMed ID: 29203275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypochlorite solution as a decontaminant in sulfur mustard contaminated skin defects in the euthymic hairless guinea pig.
    Gold MB; Bongiovanni R; Scharf BA; Gresham VC; Woodward CL
    Drug Chem Toxicol; 1994 Nov; 17(4):499-527. PubMed ID: 7821235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic options to treat sulfur mustard poisoning--the road ahead.
    Smith WJ
    Toxicology; 2009 Sep; 263(1):70-3. PubMed ID: 18852011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute intensive care unit management of mustard gas victims: the Turkish experience
    Kilic E; Ortatatli M; Sezigen S; Eyison RK; Kenar L
    Cutan Ocul Toxicol; 2018 Dec; 37(4):332-337. PubMed ID: 29648477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicology and pharmacology of the chemical warfare agent sulfur mustard.
    Dacre JC; Goldman M
    Pharmacol Rev; 1996 Jun; 48(2):289-326. PubMed ID: 8804107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of sulphur mustard skin injury.
    Jenner J; Graham SJ
    Chem Biol Interact; 2013 Dec; 206(3):491-5. PubMed ID: 24513294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of skin lesions caused by sulfur mustard.
    Vogt RF; Dannenberg AM; Schofield BH; Hynes NA; Papirmeister B
    Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S71-83. PubMed ID: 6233199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesenchymal stem cells are highly resistant to sulfur mustard.
    Schmidt A; Scherer M; Thiermann H; Steinritz D
    Chem Biol Interact; 2013 Dec; 206(3):505-11. PubMed ID: 23933411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxicity of mustard gas skin lesions.
    Petrali JP; Oglesby-Megee S
    Microsc Res Tech; 1997 May; 37(3):221-8. PubMed ID: 9144634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulphur mustard injuries of the skin. Pathophysiology and management.
    Rice P
    Toxicol Rev; 2003; 22(2):111-8. PubMed ID: 15071821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.